1. Home
  2. LGVN vs KXIN Comparison

LGVN vs KXIN Comparison

Compare LGVN & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • KXIN
  • Stock Information
  • Founded
  • LGVN 2014
  • KXIN 2015
  • Country
  • LGVN United States
  • KXIN China
  • Employees
  • LGVN N/A
  • KXIN N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • LGVN Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • LGVN 7.8M
  • KXIN 7.5M
  • IPO Year
  • LGVN 2021
  • KXIN N/A
  • Fundamental
  • Price
  • LGVN $3.27
  • KXIN $0.12
  • Analyst Decision
  • LGVN Strong Buy
  • KXIN
  • Analyst Count
  • LGVN 1
  • KXIN 0
  • Target Price
  • LGVN $12.00
  • KXIN N/A
  • AVG Volume (30 Days)
  • LGVN 11.1M
  • KXIN 1.8M
  • Earning Date
  • LGVN 08-09-2024
  • KXIN 11-26-2019
  • Dividend Yield
  • LGVN N/A
  • KXIN N/A
  • EPS Growth
  • LGVN N/A
  • KXIN N/A
  • EPS
  • LGVN N/A
  • KXIN N/A
  • Revenue
  • LGVN $978,000.00
  • KXIN $31,535,000.00
  • Revenue This Year
  • LGVN $137.24
  • KXIN N/A
  • Revenue Next Year
  • LGVN $50.77
  • KXIN N/A
  • P/E Ratio
  • LGVN N/A
  • KXIN N/A
  • Revenue Growth
  • LGVN N/A
  • KXIN N/A
  • 52 Week Low
  • LGVN $0.77
  • KXIN $0.11
  • 52 Week High
  • LGVN $36.50
  • KXIN $5.52
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 55.46
  • KXIN 41.81
  • Support Level
  • LGVN $3.36
  • KXIN $0.12
  • Resistance Level
  • LGVN $4.88
  • KXIN $0.16
  • Average True Range (ATR)
  • LGVN 0.66
  • KXIN 0.01
  • MACD
  • LGVN 0.11
  • KXIN -0.00
  • Stochastic Oscillator
  • LGVN 35.63
  • KXIN 16.05

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: